Skip to main content

and
  1. No Access

    Article

    Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genoty** on tissue and liquid biopsies

    Resistance to osimertinib in advanced EGFR-mutated non-small cell lung cancer (NSCLC) constitutes a significant challenge for clinicians either in terms of molecular diagnosis and subsequent therapeutic implicati...

    A. Leonetti, M. Verzè, R. Minari, F. Perrone, L. Gnetti in British Journal of Cancer (2024)